Preventable Amputations in High Risk Patients Up Significantly since 2005: California study
Overall, the rate of preventable amputations has decreased in the U.S., but in California there is one sub-group for which the opposite may be true.
‘Paradigm shift’ for quality database will track medical management outcomes for the first time
CHICAGO, Illinois – A new Vascular Medicine Registry will be launched in early 2017 by the Society for Vascular Surgery (SVS) and the Society for Vascular Medicine (SVM).
Dr. Jens Eldrup-Jorgensen Named New SVS PSO Medical Director
Dr. Jens Eldrup-Jorgensen has been named the new medical director of the Society for Vascular Surgery Patient Safety Organization (SVS PSO).
Six Diabetes-Related Vascular Complications - And How To Avoid Them
People who live with diabetes know they have a lot of health management to do – monitor their blood sugar, stay alert for eye problems and monitor for foot infections.
New PAD Reporting Standards Released
The Society for Vascular Surgery has released new reporting standards focused on endovascular treatment of chronic lower extremity peripheral artery disease.
Regular Walks Give Diabetics a Leg Up On Health
CHICAGO, Ill. -- Diabetics face more than food restrictions to regulate the disease. In some cases, diabetics have increased risk of losing a toe, foot or leg. Here’s why:
PAD - Know the Risks of Peripheral Arterial Disease
Donna Parks had a sensation of heaviness in her legs for a couple of years – then sharp, stabbing pains began.
SVS PSO Launches New TCAR Surveillance Project
NEW CAROTID ARTERY STENT PROCEDURE TO BE EVALUATED BY
THE SOCIETY FOR VASCULAR SURGERY PATIENT SAFETY ORGANIZATION
JVS Publishes First-Ever TOS Reporting Standards
New thoracic outlet syndrome (TOS) reporting standards have been published by the Society for Vascular Surgery (SVS) in the September 2016 issue of Journal of Vascular Surgery.
SVS, AVF Weigh in on Chronic Venous Disease Treatments at MEDCAC Panel
CHICAGO, Illinois - Vascular surgeons and vein specialists made their case for newer lower extremity chronic venous disease treatments at a recent MEDCAC panel.